Home > Healthcare & Medical Devices > Therapeutic Respiratory Devices Market

Therapeutic Respiratory Devices Market Size By Product (Positive Airway Pressure (PAP) Devices {Continuous Positive Airway Pressure [CPAP] Devices, Auto-titrating Positive Airway Pressure [APAP] Devices, Bi-level Positive Airway Pressure [BiPAP] Devices}, Oxygen Concentrators {Fixed Oxygen Concentrators, Portable Oxygen Concentrators}, Ventilators {Adult Ventilators, Neonatal Ventilators}, Inhalers {Metered Dose Inhaler [MDI], Dry Powder Inhaler [DPI], Soft Mist Inhaler [SMI]}, Nebulizers {Compressor-based Nebulizers, Piston-based Hand-held Nebulizers, Ultrasonic Nebulizers}, Humidifiers {Heated Humidifiers, Passover Humidifiers, Integrated Humidifiers, Built-in Humidifiers, Standalone Humidifiers}), By Application (COPD, Obstructive Sleep Apnea, Asthma, Respiratory Distress Syndrome, Cystic Fibrosis), By End-use (Hospital, Homecare Settings, Emergency Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028

  • Report ID: GMI696
  • Published Date: Mar 2022
  • Report Format: PDF

Industry Trends

Therapeutic Respiratory Devices Market size was valued at around USD 47 billion in 2021 and is expected to witness around 3.7% CAGR from 2022 to 2028 due to the increasing geriatric population, rise in natural disasters, and air pollution globally.
 

Therapeutic Respiratory Devices Market

Get more details on this report - Request Free Sample PDF
 

The prevalence of respiratory diseases is increasing owing to the urbanization. Along with this, technological innovation and increasing adoption of respiratory therapeutic devices are some other factors that will increase the demand for therapeutic respiratory devices. Also, World Health Organization (WHO) declared the coronavirus outbreak as a public health emergency in January 2020.
 

Since then, the number of people suffering from respiratory diseases has increased exponentially. The impact of COVID-19 on the therapeutic respiratory devices industry is observed to be positive. This is because the virus mainly attacks the respiratory system of a person. The market forged ahead with the rise in the number of cases resulting in a positive impact.
 

Therapeutic respiratory devices (TRDs) are used to improve pulmonary function, increase lung oxygenation, and aid in airway clearance by removing mucus from the bronchi. Doctors or physicians recommend therapeutic respiratory devices for the treatment of respiratory disorders because they help patients with both acute and chronic conditions. These devices require little maintenance and are simple to use.
 

Therapeutic respiratory devices are quick to deploy and aid in proper patient care. The market demand for therapeutic respiratory devices is increasing as a result of ongoing technological advancements.
 

Increase in incidences of respiratory diseases globally will upsurge the market growth over the analysis period

The global increase in the cases of respiratory diseases is one of the major factors that is driving the therapeutic respiratory devices market growth. According to the European Academy of Allergy and Clinical Immunology (EAACI) Global Atlas of Asthma 2021, more than 350 million patients around the world are suffering from asthma. Aging population and rising urbanization along with environmental and lifestyle changes trigger respiratory diseases.
 

Furthermore, there is a rising trend of using e-cigarettes in early adolescents and middle-aged people. The increasing number of smokers and smoking-related respiratory disorders are becoming more common. Thus, the rise in cases of various types of respiratory diseases and technological advancements in therapeutic devices will propel the therapeutic respiratory devices market share.
 

Increasing adoption of PAP devices will foster the therapeutic respiratory devices market over the projected timeline

Global Therapeutic Respiratory Devices Market By Product

Get more details on this report - Request Free Sample PDF
 

Based on product, the positive airway pressure devices segment accounted for around 2.5% market share in 2021 driven by growing product approval and new product launches due to technological advancements in therapeutic respiratory devices. The PAP devices are further divided into continuous positive airway pressure (CPAP) devices, auto-titrating positive airway pressure (APAP) devices, and bi-level positive airway pressure (BiPAP) devices.
 

PAP devices open patients’ airway and prevents it from collapsing while they are asleep, enabling them to breathe normally.
 

For instance, in August 2021, ResMed launched AirSense11, a next-generation PAP therapy device. It has a feature of remote software update that ease into therapy and has comfort during night use. Such innovations in therapeutic respiratory devices will upsurge market growth during the analysis period.
 

Growing COPD cases globally will boost the market revenue over the years

Global Therapeutic Respiratory Devices Market By Applications

Get more details on this report - Request Free Sample PDF
 

By application, the market is fragmented into COPD, obstructive sleep apnea, asthma, respiratory distress syndrome, cystic fibrosis, and others. Among them, the chronic obstructive pulmonary disease (COPD) segment accounted for USD 12.6 billion in 2021 owing to the rising geriatric population along with increasing air pollution in urban areas.
 

For instance, according to Sixth Annual COPD In America Survey, till 2020, it is estimated that more than 250 million people worldwide suffer from COPD because rise in exposure of smoke, and toxic particles. Furthermore, working with chemicals, dust and fumes further leads to inhalation of second-hand smoke. Moreover, new product launches to aid COPD cases will further propel the segmental growth.
 

For instance, in November 2021, Cipla launched Spirofy, a portable, wireless spirometer. The device has bacterial and viral filters making it suitable for use in outdoor camps and remote regions with power shortages.
 

Rising hospital visits for proper treatment will boost the overall industry progression

The therapeutic respiratory devices market based on the end-use is divided into hospitals, homecare settings and emergency centers. The hospitals segment accounted for around USD 17 billion in 2021 owing to the increasing healthcare expenditure to provide a proper diagnosis, treatment, and improved patient care in hospitals.
 

Furthermore, hospitals have trained professionals along with strong financials to purchase expensive medical devices. COVID-19 has also positively impacted the hospital segment. Also, according to data published by Public Health England in 2019, lung disease accounts for 700,000 hospital admissions every year. This rise in the number of diagnoses and treatments in hospitals will flourish the market growth. Such factors increase the demand for therapeutic respiratory devices in hospitals.
 

Increasing healthcare awareness in North America will enhance the market progression

North America Therapeutic Respiratory Devices Market By Country

Get more details on this report - Request Free Sample PDF
 

North America therapeutic respiratory devices market captured over 36% market share in 2021 and is expected to grow significantly during the forecast years owing to the presence of sophisticated healthcare facilities in the U.S. and Canada. Also, the increasing healthcare awareness along with improving healthcare infrastructure will augment the market growth.
 

Moreover, the increasing incidences of respiratory infections across the U.S. coupled with rising healthcare spending is also expected to propel therapeutic respiratory devices market in the forthcoming years. For instance, according to the United States Death Statistics, in 2021, 44,630 people died due to respiratory diseases.
 

The therapeutic respiratory devices industry is flooded with several global companies offering similar products

Some of the major industry players operating in the therapeutic respiratory devices industry are Aerin Medical, BMC Medical Co., Ltd., Breas Medical, CAIRE Inc., CareFusion Corporation, Covidien Plc, DeVilbiss Healthcare GmbH (Drive DeVilbiss International), Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, GE Healthcare, Hamilton Medical, Hill-Rom Services Inc., Inogen, Inc., Invacare Corporation, Koninklijke Philips N.V., Medtronic, Nidek Medical Products, Inc., O2 CONCEPTS, LLC., ResMed, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Smiths Medical, Teleflex Incorporated, VYAIRE MEDICAL, INC., WEINMANN Emergency Medical Technology GmbH and others.
 

These market participants are implementing various growth strategies, mergers and acquisitions, collaborations, and launches to enhance product capabilities to sustain market competition in the therapeutic respiratory devices industry.
 

Some of the recent industry developments:

  • In February 2021, Koninklijke Philips N.V. completed the acquisition of BioTelemetry, Inc., a U.S. based company. This helped in advancement of Philips product portfolio thus increasing its sales.
     
  • In April 2021, Smiths Medical launched Acapella, a choice blue vibratory PAP therapy system. It is a drug-free supplemental treatment that aid in the removal of secretions for patients who have asthma, COPD, cystic fibrosis, and lung disease.
     

The therapeutic respiratory devices market report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD from 2022 to 2028, for the following segments:

By Product

  • Positive Airway Pressure (PAP) Devices
    • Continuous Positive Airway Pressure (CPAP) Devices
    • Auto-titrating Positive Airway Pressure (APAP) Devices
    • Bi-level Positive Airway Pressure (BiPAP) Devices
  • Oxygen Concentrator 
    • Fixed Oxygen Concentrators
    • Portable Oxygen Concentrators
  • Ventilators 
    • Adult Ventilators
    • Neonatal Ventilators
  • Inhalers 
    • Metered Dose Inhaler (MDI)
    • Dry Powder Inhaler (DPI)
    • Soft Mist Inhaler (SMI)  
  • Nebulizers   
    • Compressor-based Nebulizers
    • Piston-based Hand-held Nebulizers
    • Ultrasonic Nebulizers
  • Humidifiers 
    • Heated Humidifiers
    • Passover Humidifiers
    • Integrated Humidifiers
    • Built-in Humidifiers
    • Standalone Humidifiers   
  • Others

By Application

  • COPD
  • Obstructive Sleep Apnea
  • Asthma
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Others

By End-use

  • Hospital
  • Homecare Settings
  • Emergency Centers

The above information is provided for the following regions and countries:

By Region

  • North America 
    • U.S.
    • Canada
  • Europe 
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific 
    • Japan
    • China
    • India
  • Latin America 
    • Brazil
    • Mexico
  • Middle East and Africa 
    • South Africa
    • UAE
    • Saudi Arabia

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for therapeutic respiratory devices exceeded USD 47 billion in 2021 and is anticipated to grow at a CAGR of 3.7% between 2022 and 2028 owing to an increase in air pollution and natural disasters at the global level.

The market value from PAP devices accounted for around 2.5% of the overall industry revenue in 2021 and is expected to depict appreciable growth impelled by new product launches and an increase in product approvals.

North American market for therapeutic respiratory devices captured around 36% of the total industry size in 2021 and will exhibit lucrative growth driven by the presence of sophisticated healthcare facilities in Canada and the U.S.

Leading companies in the therapeutic respiratory devices industry comprise Covidien Plc, BMC Medical Co., Ltd., Inogen, Inc., ResMed, Inc., CAIRE Inc., Aerin Medical, Hamilton Medical, Invacare Corporation, and others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 24
  • Tables & Figures: 520
  • Countries covered: 15
  • Pages: 374

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount